These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38802199)

  • 1. The role of probiotics as adjunct treatment in the prevention and management of gynecological infections: An updated meta-analysis of 35 RCT studies.
    Abavisani M; Sahebi S; Dadgar F; Peikfalak F; Keikha M
    Taiwan J Obstet Gynecol; 2024 May; 63(3):357-368. PubMed ID: 38802199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics for vulvovaginal candidiasis in non-pregnant women.
    Xie HY; Feng D; Wei DM; Mei L; Chen H; Wang X; Fang F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD010496. PubMed ID: 29168557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
    van de Wijgert J; Verwijs MC
    BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial.
    Chen R; Li R; Qing W; Zhang Y; Zhou Z; Hou Y; Shi Y; Zhou H; Chen M
    Reprod Health; 2022 Jun; 19(1):137. PubMed ID: 35698149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis.
    Zahedifard T; Khadivzadeh T; Rakhshkhorshid M
    Ethiop J Health Sci; 2023 Sep; 33(5):881-890. PubMed ID: 38784519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics and vaginal microecology: fact or fancy?
    Buggio L; Somigliana E; Borghi A; Vercellini P
    BMC Womens Health; 2019 Jan; 19(1):25. PubMed ID: 30704451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics for Treatment and Prevention of Urogenital Infections in Women: A Systematic Review.
    Hanson L; VandeVusse L; Jermé M; Abad CL; Safdar N
    J Midwifery Womens Health; 2016 May; 61(3):339-55. PubMed ID: 27218592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics for the treatment of bacterial vaginosis.
    Senok AC; Verstraelen H; Temmerman M; Botta GA
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006289. PubMed ID: 19821358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials.
    Li C; Wang T; Li Y; Zhang T; Wang Q; He J; Wang L; Li L; Yang N; Fang Y
    Eur J Pharmacol; 2019 Dec; 864():172660. PubMed ID: 31562865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review and meta-analysis on the efficacy of probiotics for bacterial vaginosis.
    Liu HF; Yi N
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):90-98. PubMed ID: 35049024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.
    Marrazzo JM; Dombrowski JC; Wierzbicki MR; Perlowski C; Pontius A; Dithmer D; Schwebke J
    Clin Infect Dis; 2019 Feb; 68(5):803-809. PubMed ID: 30184181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating vaginitis with probiotics in non-pregnant females: A systematic review and meta-analysis.
    Jeng HS; Yan TR; Chen JY
    Exp Ther Med; 2020 Oct; 20(4):3749-3765. PubMed ID: 32855726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics for the Treatment of Bacterial Vaginosis: A Meta-Analysis.
    Wang Z; He Y; Zheng Y
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31614736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials.
    Huang H; Song L; Zhao W
    Arch Gynecol Obstet; 2014 Jun; 289(6):1225-34. PubMed ID: 24318276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
    Abad CL; Safdar N
    J Chemother; 2009 Jun; 21(3):243-52. PubMed ID: 19567343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of
    Mändar R; Sõerunurk G; Štšepetova J; Smidt I; Rööp T; Kõljalg S; Saare M; Ausmees K; Le DD; Jaagura M; Piiskop S; Tamm H; Salumets A
    Benef Microbes; 2023 Apr; 14(2):143-152. PubMed ID: 36856121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary results of Lacofem trial--first impressions].
    Sigridov I; Ivanov S; Batashki I
    Akush Ginekol (Sofiia); 2007; 46 Suppl 2():29-32. PubMed ID: 18173005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.